Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
371 studies found for:    leukemia [CONDITION] AND child [AGE-GROUP] | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
Condition: Leukemia
Intervention: Drug: Ara-c
2 Recruiting Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL
Condition: Leukemia
Interventions: Drug: Amsacrine;   Drug: Clofarabine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin hydrochloride;   Drug: Dexamethasone;   Drug: Doxorubicin hydrochloride;   Drug: Etoposide phosphate;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Pegaspargase;   Drug: Thioguanine;   Drug: Vincristine sulfate;   Radiation: Whole-brain radiation therapy
3 Recruiting International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010
Condition: Acute Lymphoblastic Leukemia (ALL)
Interventions: Drug: SR-A + Epratuzumab;   Drug: SR-B + Epratuzumab
4 Recruiting Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HR First Relapse B-precursor ALL
Condition: Leukemia, Acute Lymphoblastic
Interventions: Drug: Blinatumomab;   Drug: Conventional Consolidation Chemotherapy
5 Recruiting International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
Condition: Acute Myeloid Leukaemia
Interventions: Drug: Gemtuzumab ozogamicin;   Drug: Liposomal daunorubicin;   Drug: Mitoxantrone;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Busulfan;   Drug: Cyclophosphamide
6 Recruiting Prevalence of Psychocognitive Impairments in Adolescents Surviving Childhood Leukemia : LEA-PsyCog
Condition: Adolescents Surviving Childhood Leukemia LEA
Intervention: Other: neuropsychological evaluation
7 Recruiting Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML
Condition: Leukemia, Myeloid, Acute
Intervention: Drug: G-CSF
8 Recruiting Study of Blood Samples From Newborns With Down Syndrome
Condition: Leukemia
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: pharmacological study
9 Recruiting Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Condition: Leukemia
Interventions: Drug: Bortezomib;   Drug: Pravastatin
10 Recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: ITMHA;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Pegaspargase;   Drug: Asparaginase Erwinia Chrysanthemi;   Drug: Bortezomib;   Drug: Vorinostat;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Leucovorin Calcium;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Vincristine
11 Recruiting The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: 6-mercaptopurine, Methotrexate;   Drug: 6-mercaptopurine, Methotrexate, Vincristine, Dexamethasone
12 Recruiting Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: ATRA;   Drug: ATRA + IDA
13 Recruiting Epigenetic Reprogramming in Relapse AML
Condition: Leukemia, Acute Myeloid
Interventions: Drug: Decitabine;   Drug: Vorinostat;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim;   Drug: Sorafenib
14 Recruiting Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML
Condition: Acute Myeloid Leukemia
Interventions: Drug: Idarubicin;   Drug: Cytarabine;   Drug: Cyclophosphamide;   Drug: Physician-Directed Regimens without Cyclophosphamide
15 Recruiting Azacytidine Plus FLAG for Relapsed or Refractory AML
Condition: Acute Myeloid Leukemia
Interventions: Drug: Azacytidine;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim
16 Recruiting Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
Condition: Acute Myeloid Leukemia
Intervention: Drug: Interferon-alpha
17 Not yet recruiting Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant
Condition: Acute Myeloid Leukemia in Children
Interventions: Procedure: CIML NK Cell Infusion;   Procedure: CD3+ T Cell Product Infusion;   Procedure: Peripheral blood draw
18 Recruiting Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
Condition: Acute Lymphoblastic Leukemia (ALL)
Interventions: Drug: Prednisolone;   Drug: Dexamethasone;   Drug: L-Asparaginase;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Daunorubicin;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: 6-Mercaptopurine;   Drug: Thioguanine;   Drug: Fludarabine;   Drug: Imatinib
19 Recruiting Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation
Condition: Leukemia
Intervention: Other: DLI of the 20 fraction of the UCBT
20 Recruiting Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies
Conditions: B-Cell Leukemia;   B-Cell Lymphoma
Interventions: Biological: 4SCAR19/22 T cells;   Drug: Interleukin-2

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.